Skip to main content
Clinical Trials/IRCT20220508054780N4
IRCT20220508054780N4
Not yet recruiting
Phase 1

A clinical trial to compare the effectiveness of agomelatine with placebo on rate of delirium in patients admitted to the cardiac surgery intensive care unit

Mashhad University of Medical Sciences0 sites74 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
74
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 and 75 years
  • Staying more than 72 hours in the intensive care unit
  • Receiving medication following admission to hospital from the first day
  • Having stable hemodynamics based on confusion assessment method for the ICU (CAM\-ICU)

Exclusion Criteria

  • Patients who were treated with agomelatine before ICU admission
  • Having agomelatine allergies
  • Pregnant and breastfeeding women
  • Having Alzheimer
  • Having hepatic dysfunction
  • Having high APACHE II score
  • The patient dies in the first 3 days of admission
  • Patients who require of only parenteral nutrition
  • Using strong 1A2 inhibitors (ciprofloxacin, fluvoxamine)

Outcomes

Primary Outcomes

Not specified

Similar Trials